Close Menu

NEW YORK (GenomeWeb News) – Mayo Clinic is partnering with three US healthcare groups to study if prescribing heart medications based on a patient's genotype will improve outcomes in angioplasty patients, NorthShore University HealthSystem, one of the project partners, said today.

The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) study seeks to find out if testing for a patient's genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo angioplasty.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.